Statistics

Total Visits

Views
Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial65

File Visits

Downloads
7415-31389.pdf22

Select a period of time:

Number of views in the range

Views
Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial48

Number of downloads in the range

Downloads

Views

Views
February 20250
March 202514
April 20251
May 20257
June 20259
July 202516
August 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore29
Brazil7
United States4
Germany2
Canada1
United Kingdom1
Hong Kong1
Tunisia1
Venezuela1
South Africa1
 

Top cities views

Views
Aachen1
Averill Park1
Cafelândia1
Camaragibe1
Council Bluffs1
Garibaldi1
Hong Kong1
Juazeiro do Norte1
Leeds1
Maracaibo1